NCLEX RN Exam Bank on Chronic Disease Management,
Diabetes, Hypertension, COPD
Table of Contents
Subtopic 1: Pathophysiology and Disease Progression of Diabetes, Hypertension, and
COPD........................................................................................................................... 2
Subtopic 2: Pharmacologic Management of Diabetes, Hypertension, and COPD ............. 10
Subtopic 3: Lifestyle Modification and Patient Education in Chronic Disease Management
.................................................................................................................................. 19
Subtopic 4: Complications and Emergency Management in Chronic Diseases ................ 28
Subtopic 5: Pharmacologic Management and Patient Education in Chronic Disease ........ 37
Subtopic 6: Medication Management, Adherence, and Patient Education ....................... 45
Subtopic 7: Patient Teaching & Self-Management Strategies .......................................... 53
Subtopic 7: Hypertension—Pharmacologic & Lifestyle Interventions .............................. 62
Subtopic 8: Nutrition and Lifestyle Modifications in Chronic Disease Management .......... 70
Subtopic 9: Interprofessional Collaboration & Referral Management .............................. 78
Subtopic 10: Discharge Planning, Community Resources & Patient-Centered Care ......... 85
, 2
Subtopic 1: Pathophysiology and Disease Progression of
Diabetes, Hypertension, and COPD
(Questions 1–20)
Question 1:
Which of the following best explains the underlying pathophysiology of Type 2 Diabetes
Mellitus?
A. Autoimmune destruction of pancreatic beta cells
B. Insulin resistance and progressive beta-cell dysfunction
C. Excess insulin production due to a pituitary disorder
D. Inflammation of the exocrine pancreas
Correct Answer: B
Rationale: Type 2 diabetes is primarily characterized by insulin resistance in muscle and
liver cells and a gradual decline in beta-cell function, leading to insufficient insulin
production over time.
Question 2:
Which physiological change is most associated with the development of essential
hypertension?
A. Decreased sympathetic nervous activity
B. Increased systemic vascular resistance
C. Reduced aldosterone production
D. Enhanced nitric oxide production
Correct Answer: B
, 3
Rationale: Increased systemic vascular resistance due to vasoconstriction and vascular
remodeling contributes significantly to the development of essential hypertension.
Question 3:
In COPD, which pathological process leads to decreased gas exchange?
A. Hyperplasia of alveolar type I cells
B. Excess surfactant production
C. Alveolar wall destruction and air trapping
D. Increased mucociliary clearance
Correct Answer: C
Rationale: COPD involves destruction of alveolar walls and air trapping, reducing surface
area for gas exchange and contributing to chronic hypoxia.
Question 4:
Which of the following hormones contributes to insulin resistance in Type 2 Diabetes?
A. Estrogen
B. Cortisol
C. Oxytocin
D. Parathyroid hormone
Correct Answer: B
Rationale: Cortisol, a glucocorticoid, increases blood glucose levels and contributes to
insulin resistance when elevated chronically, as seen in stress or Cushing’s syndrome.
Question 5:
What is the role of angiotensin II in the pathophysiology of hypertension?
, 4
A. Promotes sodium excretion
B. Dilates systemic blood vessels
C. Stimulates vasoconstriction and aldosterone secretion
D. Decreases sympathetic tone
Correct Answer: C
Rationale: Angiotensin II causes vasoconstriction and stimulates aldosterone secretion
from the adrenal cortex, leading to sodium and water retention and increased BP.
Question 6:
Which of the following structural changes occur in chronic bronchitis, a type of COPD?
A. Alveolar rupture
B. Thinning of the bronchial walls
C. Hypertrophy of mucus glands and chronic inflammation
D. Bronchial smooth muscle atrophy
Correct Answer: C
Rationale: Chronic bronchitis involves glandular hypertrophy, excessive mucus production,
and chronic inflammation, leading to airway obstruction.
Question 7:
Which biomarker is most indicative of long-term glucose control in diabetic patients?
A. Serum glucose
B. Insulin level
C. Hemoglobin A1c
D. Glucagon level